These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 5640914)
41. [A clinical study of substance dependence patients combined with other psychiatric disorders]. Kuwata T; Suwaki H Nihon Arukoru Yakubutsu Igakkai Zasshi; 1998 Oct; 33(5):574-86. PubMed ID: 9844377 [TBL] [Abstract][Full Text] [Related]
42. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Kendler KS; Myers J; Prescott CA Arch Gen Psychiatry; 2007 Nov; 64(11):1313-20. PubMed ID: 17984400 [TBL] [Abstract][Full Text] [Related]
43. [Variables related to risk taking behavior for HIV transmission among drug-dependent patients]. Cervera G; Valderrama JC; Bolinches F; Salazar A; MartÃnez J Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(3):155-64. PubMed ID: 9717340 [TBL] [Abstract][Full Text] [Related]
44. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. Elander J; Lusher J; Bevan D; Telfer P; Burton B J Pain Symptom Manage; 2004 Feb; 27(2):156-69. PubMed ID: 15157040 [TBL] [Abstract][Full Text] [Related]
45. Comorbidity between alcohol dependence and illicit drug dependence in adolescents with antisocial behavior and matched controls. Rhee SH; Hewitt JK; Young SE; Corley RP; Crowley TJ; Neale MC; Stallings MC Drug Alcohol Depend; 2006 Sep; 84(1):85-92. PubMed ID: 16413148 [TBL] [Abstract][Full Text] [Related]
46. [Sports, use of performance enhancing drugs and addiction. A conceptual and epidemiological review]. Franques P; Auriacombe M; Tignol J Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():37-49. PubMed ID: 11965097 [TBL] [Abstract][Full Text] [Related]
48. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders]. Liraud F; Verdoux H Encephale; 2002; 28(2):160-8. PubMed ID: 11972143 [TBL] [Abstract][Full Text] [Related]
49. Proceedings: Pharmacokinetic and stereo-chemical studies on diethylpropion and related compounds in man. Beckett AH Acta Pharm Suec; 1974 Dec; 11(6):641. PubMed ID: 1136793 [No Abstract] [Full Text] [Related]
52. Diethylpropion-induced psychosis reprecipitated by an MAO inhibitor: case report. Martin CA; Iwamoto ET J Clin Psychiatry; 1984 Mar; 45(3):130-1. PubMed ID: 6698946 [TBL] [Abstract][Full Text] [Related]
53. Diethylpropion, an appetite suppressant. Med Lett Drugs Ther; 1971 Dec; 13(25):101-2. PubMed ID: 5164044 [No Abstract] [Full Text] [Related]
54. [Abuse of amfepramon (dietlylpropione)]. Durling U Lakartidningen; 1966 Nov; 63(46):4362-3. PubMed ID: 5979937 [No Abstract] [Full Text] [Related]
55. Diethylpropion: the risk of dependence. Drug Ther Bull; 1968 Feb; 6(3):12. PubMed ID: 5640914 [No Abstract] [Full Text] [Related]